Form C-AR — Rejuvine Life Sciences, Inc.
0002008980-25-000001 · filed Apr 17, 2025
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 2008980
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 651 North Broad Street
Middletown, DE 19709 - Phone
- —
Most recent fiscal year financials
- Total assets
- $4,075,294
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $3,910,000
- Revenues
- $47,234
- COGS
- $21,121
- Taxes paid
- —
- Net income
- $-115,455
View the original filing on SEC EDGAR ↗